Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP)

Historical Holders from Q4 2022 to Q3 2025

Symbol
COCP on Nasdaq
CUSIP
19188J409
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
13.8M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
665K
Holdings value
$831K
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
21
Number of buys
7
Number of sells
-8
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FROST PHILLIP MD ET AL 17.8% +65.5% $3.08M $1.35M 2.46M +78% Phillip Frost, M.D. Oct 28, 2025

Institutional Holders of Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 665K $831K -$40.1K $1.25 21
2025 Q2 687K $1.02M -$87.9K $1.49 21
2025 Q1 749K $1.06M +$47.1K $1.42 23
2024 Q4 711K $1.44M -$16K $2.02 24
2024 Q3 719K $1.27M +$79.1K $1.76 19
2024 Q2 674K $1.57M -$90.5K $2.33 13
2024 Q1 721K $1.01M +$54K $1.40 14
2023 Q4 683K $1.17M -$61.1K $1.72 16
2023 Q3 704K $1.32M +$61.5K $1.87 15
2023 Q2 667K $1.59M -$145K $2.39 19
2023 Q1 739K $1.47M -$652K $1.99 19
2022 Q4 1.07M $2.08M +$2.08M $1.95 18